Diabetes and Dyslipidemia Screening in Pediatric Practice.

Jordyn Huston, Deepti Sudhakar, Poornaashri Malarvannan, Riya Aradhyula, Amy L Clark

Abstract read

In one paragraph

Article in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jordyn HustonDepartment of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri.

Deepti SudhakarSaint Louis University School of Medicine, St. Louis, Missouri.

Poornaashri MalarvannanDepartment of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri.

Riya AradhyulaSaint Louis University, St. Louis, Missouri.

Amy L ClarkDepartment of Pediatrics, Division of Endocrinology, Saint Louis University School of Medicine, SSM Health Cardinal Glennon, St. Louis, Missouri.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of diabetes and hyperlipidemia are increasing at rapid rates in children. These conditions are associated with increased risk of macrovascular and microvascular complications causing major morbidity and mortality later in life. Early diagnosis and treatment can reduce the lifelong risk of complications from these diseases, exemplifying the importance of screening in the pediatric population. The following article presents a summary of the current guidelines for diabetes and hyperlipidemia screening in pediatric patients.

Indexed as

DyslipidemiasMass ScreeningAdolescentChildDiabetes MellitusHumansHyperlipidemiasPediatricsPractice Guidelines as Topic

Identifiers

PMID38854609

PMCPMC11160381

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.